Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 9/20 | 0.36 |
| ▸ | CTSL | P07711 | 6/20 | 0.35 |
| ▸ | CTSB | P07858 | 6/20 | 0.35 |
| ▸ | CTSH | P09668 | 4/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24144 | 0.98 | ALDH1A1 (0.34) | CTSKCTSLCTSBCTSHCPB2 | |
| SCHEMBL31676625 | 0.89 | — | — | |
| SCHEMBL175124 | 0.88 | CTSK (0.35) | CTSKCTSLCTSBCTSHCPB2 | |
| SCHEMBL20272927 | 0.88 | CTSK (0.35) | CTSKCTSLCTSBCTSHCPB2 | |
| SCHEMBL12631778 | 0.82 | CTSK (0.39) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL14261875 | 0.82 | CTSK (0.39) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL6156682 | 0.82 | CTSK (0.39) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL3155857 | 0.81 | CYP1A2 (0.40) | CTSKCTSLCTSBCTSHLTA4H | |
| SCHEMBL113352 | 0.81 | METAP1 (0.43) | ALDH1A1ALOX15 | |
| SCHEMBL2059106 | 0.80 | CTSD (0.37) | CTSKCTSLCTSBCTSHCPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2609184-B1 | PERFUMERY COMPOSITIONS AND SYNTHESIS OF A ODORANT | VAZE KEDAR RAMESH (IN) | 2017-02-15 | — | — | EP | claimed |
| EP-2609184-A1 | SYNTHESIS OF A NOVEL ODORANT | Vaze, Kedar Ramesh (IN) | 2013-07-03 | — | — | EP | claimed |
| US-20130157923-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2013-06-20 | — | — | US | claimed |
| WO-2012025934-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2012-03-01 | — | — | WO | claimed |
| US-11655216-B2 | Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use | MERCK SHARP & DOHME LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-9845443-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2017-12-19 | — | — | US | disclosed |
| US-9845443-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2017-12-19 | — | — | US | disclosed |
| US-9845443-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2017-12-19 | — | — | US | disclosed |
| EP-2609184-B1 | PERFUMERY COMPOSITIONS AND SYNTHESIS OF A ODORANT | VAZE KEDAR RAMESH (IN) | 2017-02-15 | — | — | EP | disclosed |
| EP-2609184-B1 | PERFUMERY COMPOSITIONS AND SYNTHESIS OF A ODORANT | VAZE KEDAR RAMESH (IN) | 2017-02-15 | — | — | EP | disclosed |
| US-20160024424-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2016-01-28 | — | — | US | disclosed |
| US-20160024424-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2016-01-28 | — | — | US | disclosed |
| US-9187709-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2015-11-17 | — | — | US | disclosed |
| US-9187709-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2015-11-17 | — | — | US | disclosed |
| EP-2609184-A1 | SYNTHESIS OF A NOVEL ODORANT | Vaze, Kedar Ramesh (IN) | 2013-07-03 | — | — | EP | disclosed |
| US-20130157923-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2013-06-20 | — | — | US | disclosed |
| US-20130157923-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2013-06-20 | — | — | US | disclosed |
| US-20130157923-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2013-06-20 | — | — | US | disclosed |
| WO-2012025934-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012025934-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024424-A1 | SYNTHESIS OF A NOVEL ODORANT | OR10J3, OR51E2, TAS2R10 | CTSK 4251/4885CTSL 4603/4885CTSB 4696/4885 |
| US-11655216-B2 | Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use | NR1H2, NR1H3, NR1H4 | CTSK 3783/4885CTSL 3232/4885CTSB 2824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.